 | • レポートコード：QYR2104Z1823 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、158ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、糖尿病用治療・診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（インスリン、インスリンデリバリー、経口血糖降下薬、診断・モニタリング、その他）、用途別市場規模（1型糖尿病、2型糖尿病、妊娠糖尿病、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・糖尿病用治療・診断の市場動向 ・企業の競争状況、市場シェア ・糖尿病用治療・診断の種類別市場規模（インスリン、インスリンデリバリー、経口血糖降下薬、診断・モニタリング、その他） ・糖尿病用治療・診断の用途別市場規模（1型糖尿病、2型糖尿病、妊娠糖尿病、その他） ・糖尿病用治療・診断の北米市場規模2016-2027（アメリカ、カナダ） ・糖尿病用治療・診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・糖尿病用治療・診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・糖尿病用治療・診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・糖尿病用治療・診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（77 Elektronika Kft.、A. Menarini Diagnostics S.R.L、Abbott Laboratories、Agamatrix Inc.、Animas Corp.、Ascensia、Becton Dickinson、Debiotech S.A.、Eli Lilly And Co.、Glaxo Smithkline、Inlight Solutions Inc.、Johnson & Johnson、Lifescan Inc.、Medtronic、Merck & Co.、Merck KGAA、Nipro Corp.、Novartis Pharma Ag、Novo Nordisk A/S、Owen Mumford Ltd.、Palco Labs Inc.、Roche、Sanofi、Takeda Pharmaceutical Co. Ltd.、Terumo Corp.） ・結論 |
This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.
Market Analysis and Insights: Global Diabetes Therapeutics and Diagnostics Market
The global Diabetes Therapeutics and Diagnostics market size is projected to reach US$ 140000 million by 2026, from US$ 117590 million in 2019, at a CAGR of 2.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetes Therapeutics and Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetes Therapeutics and Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetes Therapeutics and Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetes Therapeutics and Diagnostics market.
Global Diabetes Therapeutics and Diagnostics Scope and Market Size
Diabetes Therapeutics and Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diabetes Therapeutics and Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Insulin
Insulin Delivery
Oral Hypoglycemic Drugs
Diagnosis And Monitoring
Others
Segment by Application
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
77 Elektronika Kft.
A. Menarini Diagnostics S.R.L
Abbott Laboratories
Agamatrix Inc.
Animas Corp.
Ascensia
Becton Dickinson
Debiotech S.A.
Eli Lilly And Co.
Agamatrix Inc.
Animas Corp.
Johnson & Johnson
Lifescan Inc.
Medtronic
Merck & Co.
Merck KGAA
Nipro Corp.
Novartis Pharma Ag
Novo Nordisk A/S
Owen Mumford Ltd.
Palco Labs Inc.
Roche
Sanofi
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Insulin
1.2.3 Insulin Delivery
1.2.4 Oral Hypoglycemic Drugs
1.2.5 Diagnosis And Monitoring
1.2.6 Others
1.3 Market by Application
1.3.1 Global Diabetes Therapeutics and Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Type 1 Diabetes
1.3.3 Type 2 Diabetes
1.3.4 Gestational Diabetes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Therapeutics and Diagnostics Market Perspective (2016-2027)
2.2 Diabetes Therapeutics and Diagnostics Growth Trends by Regions
2.2.1 Diabetes Therapeutics and Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diabetes Therapeutics and Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Diabetes Therapeutics and Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Diabetes Therapeutics and Diagnostics Industry Dynamic
2.3.1 Diabetes Therapeutics and Diagnostics Market Trends
2.3.2 Diabetes Therapeutics and Diagnostics Market Drivers
2.3.3 Diabetes Therapeutics and Diagnostics Market Challenges
2.3.4 Diabetes Therapeutics and Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Therapeutics and Diagnostics Players by Revenue
3.1.1 Global Top Diabetes Therapeutics and Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Diabetes Therapeutics and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetes Therapeutics and Diagnostics Revenue
3.4 Global Diabetes Therapeutics and Diagnostics Market Concentration Ratio
3.4.1 Global Diabetes Therapeutics and Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Therapeutics and Diagnostics Revenue in 2020
3.5 Diabetes Therapeutics and Diagnostics Key Players Head office and Area Served
3.6 Key Players Diabetes Therapeutics and Diagnostics Product Solution and Service
3.7 Date of Enter into Diabetes Therapeutics and Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Therapeutics and Diagnostics Breakdown Data by Type
4.1 Global Diabetes Therapeutics and Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Diabetes Therapeutics and Diagnostics Forecasted Market Size by Type (2022-2027)
5 Diabetes Therapeutics and Diagnostics Breakdown Data by Application
5.1 Global Diabetes Therapeutics and Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Diabetes Therapeutics and Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Diabetes Therapeutics and Diagnostics Market Size (2016-2027)
6.2 North America Diabetes Therapeutics and Diagnostics Market Size by Type
6.2.1 North America Diabetes Therapeutics and Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Diabetes Therapeutics and Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Diabetes Therapeutics and Diagnostics Market Size by Type (2016-2027)
6.3 North America Diabetes Therapeutics and Diagnostics Market Size by Application
6.3.1 North America Diabetes Therapeutics and Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Diabetes Therapeutics and Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Diabetes Therapeutics and Diagnostics Market Size by Application (2016-2027)
6.4 North America Diabetes Therapeutics and Diagnostics Market Size by Country
6.4.1 North America Diabetes Therapeutics and Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Diabetes Therapeutics and Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Diabetes Therapeutics and Diagnostics Market Size (2016-2027)
7.2 Europe Diabetes Therapeutics and Diagnostics Market Size by Type
7.2.1 Europe Diabetes Therapeutics and Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Diabetes Therapeutics and Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Diabetes Therapeutics and Diagnostics Market Size by Type (2016-2027)
7.3 Europe Diabetes Therapeutics and Diagnostics Market Size by Application
7.3.1 Europe Diabetes Therapeutics and Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Diabetes Therapeutics and Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Diabetes Therapeutics and Diagnostics Market Size by Application (2016-2027)
7.4 Europe Diabetes Therapeutics and Diagnostics Market Size by Country
7.4.1 Europe Diabetes Therapeutics and Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Diabetes Therapeutics and Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Type
8.2.1 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Application
8.3.1 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Region
8.4.1 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Diabetes Therapeutics and Diagnostics Market Size (2016-2027)
9.2 Latin America Diabetes Therapeutics and Diagnostics Market Size by Type
9.2.1 Latin America Diabetes Therapeutics and Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Diabetes Therapeutics and Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Diabetes Therapeutics and Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Diabetes Therapeutics and Diagnostics Market Size by Application
9.3.1 Latin America Diabetes Therapeutics and Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Diabetes Therapeutics and Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Diabetes Therapeutics and Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Diabetes Therapeutics and Diagnostics Market Size by Country
9.4.1 Latin America Diabetes Therapeutics and Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Diabetes Therapeutics and Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Type
10.2.1 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Application
10.3.1 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Country
10.4.1 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 77 Elektronika Kft.
11.1.1 77 Elektronika Kft. Company Details
11.1.2 77 Elektronika Kft. Business Overview
11.1.3 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Introduction
11.1.4 77 Elektronika Kft. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.1.5 77 Elektronika Kft. Recent Development
11.2 A. Menarini Diagnostics S.R.L
11.2.1 A. Menarini Diagnostics S.R.L Company Details
11.2.2 A. Menarini Diagnostics S.R.L Business Overview
11.2.3 A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Introduction
11.2.4 A. Menarini Diagnostics S.R.L Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.2.5 A. Menarini Diagnostics S.R.L Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Diabetes Therapeutics and Diagnostics Introduction
11.3.4 Abbott Laboratories Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.3.5 Abbott Laboratories Recent Development
11.4 Agamatrix Inc.
11.4.1 Agamatrix Inc. Company Details
11.4.2 Agamatrix Inc. Business Overview
11.4.3 Agamatrix Inc. Diabetes Therapeutics and Diagnostics Introduction
11.4.4 Agamatrix Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.4.5 Agamatrix Inc. Recent Development
11.5 Animas Corp.
11.5.1 Animas Corp. Company Details
11.5.2 Animas Corp. Business Overview
11.5.3 Animas Corp. Diabetes Therapeutics and Diagnostics Introduction
11.5.4 Animas Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.5.5 Animas Corp. Recent Development
11.6 Ascensia
11.6.1 Ascensia Company Details
11.6.2 Ascensia Business Overview
11.6.3 Ascensia Diabetes Therapeutics and Diagnostics Introduction
11.6.4 Ascensia Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.6.5 Ascensia Recent Development
11.7 Becton Dickinson
11.7.1 Becton Dickinson Company Details
11.7.2 Becton Dickinson Business Overview
11.7.3 Becton Dickinson Diabetes Therapeutics and Diagnostics Introduction
11.7.4 Becton Dickinson Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.7.5 Becton Dickinson Recent Development
11.8 Debiotech S.A.
11.8.1 Debiotech S.A. Company Details
11.8.2 Debiotech S.A. Business Overview
11.8.3 Debiotech S.A. Diabetes Therapeutics and Diagnostics Introduction
11.8.4 Debiotech S.A. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.8.5 Debiotech S.A. Recent Development
11.9 Eli Lilly And Co.
11.9.1 Eli Lilly And Co. Company Details
11.9.2 Eli Lilly And Co. Business Overview
11.9.3 Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Introduction
11.9.4 Eli Lilly And Co. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.9.5 Eli Lilly And Co. Recent Development
11.10 Glaxo Smithkline
11.10.1 Glaxo Smithkline Company Details
11.10.2 Glaxo Smithkline Business Overview
11.10.3 Glaxo Smithkline Diabetes Therapeutics and Diagnostics Introduction
11.10.4 Glaxo Smithkline Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.10.5 Glaxo Smithkline Recent Development
11.11 Inlight Solutions Inc.
11.11.1 Inlight Solutions Inc. Company Details
11.11.2 Inlight Solutions Inc. Business Overview
11.11.3 Inlight Solutions Inc. Diabetes Therapeutics and Diagnostics Introduction
11.11.4 Inlight Solutions Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.11.5 Inlight Solutions Inc. Recent Development
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Details
11.12.2 Johnson & Johnson Business Overview
11.12.3 Johnson & Johnson Diabetes Therapeutics and Diagnostics Introduction
11.12.4 Johnson & Johnson Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.12.5 Johnson & Johnson Recent Development
11.13 Lifescan Inc.
11.13.1 Lifescan Inc. Company Details
11.13.2 Lifescan Inc. Business Overview
11.13.3 Lifescan Inc. Diabetes Therapeutics and Diagnostics Introduction
11.13.4 Lifescan Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.13.5 Lifescan Inc. Recent Development
11.14 Medtronic
11.14.1 Medtronic Company Details
11.14.2 Medtronic Business Overview
11.14.3 Medtronic Diabetes Therapeutics and Diagnostics Introduction
11.14.4 Medtronic Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.14.5 Medtronic Recent Development
11.15 Merck & Co.
11.15.1 Merck & Co. Company Details
11.15.2 Merck & Co. Business Overview
11.15.3 Merck & Co. Diabetes Therapeutics and Diagnostics Introduction
11.15.4 Merck & Co. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.15.5 Merck & Co. Recent Development
11.16 Merck KGAA
11.16.1 Merck KGAA Company Details
11.16.2 Merck KGAA Business Overview
11.16.3 Merck KGAA Diabetes Therapeutics and Diagnostics Introduction
11.16.4 Merck KGAA Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.16.5 Merck KGAA Recent Development
11.17 Nipro Corp.
11.17.1 Nipro Corp. Company Details
11.17.2 Nipro Corp. Business Overview
11.17.3 Nipro Corp. Diabetes Therapeutics and Diagnostics Introduction
11.17.4 Nipro Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.17.5 Nipro Corp. Recent Development
11.18 Novartis Pharma Ag
11.18.1 Novartis Pharma Ag Company Details
11.18.2 Novartis Pharma Ag Business Overview
11.18.3 Novartis Pharma Ag Diabetes Therapeutics and Diagnostics Introduction
11.18.4 Novartis Pharma Ag Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.18.5 Novartis Pharma Ag Recent Development
11.18 Novo Nordisk A/S
11.25.1 Novo Nordisk A/S Company Details
11.25.2 Novo Nordisk A/S Business Overview
11.25.3 Novo Nordisk A/S Diabetes Therapeutics and Diagnostics Introduction
11.25.4 Novo Nordisk A/S Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.25.5 Novo Nordisk A/S Recent Development
11.20 Owen Mumford Ltd.
11.20.1 Owen Mumford Ltd. Company Details
11.20.2 Owen Mumford Ltd. Business Overview
11.20.3 Owen Mumford Ltd. Diabetes Therapeutics and Diagnostics Introduction
11.20.4 Owen Mumford Ltd. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.20.5 Owen Mumford Ltd. Recent Development
11.21 Palco Labs Inc.
11.21.1 Palco Labs Inc. Company Details
11.21.2 Palco Labs Inc. Business Overview
11.21.3 Palco Labs Inc. Diabetes Therapeutics and Diagnostics Introduction
11.21.4 Palco Labs Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.21.5 Palco Labs Inc. Recent Development
11.22 Roche
11.22.1 Roche Company Details
11.22.2 Roche Business Overview
11.22.3 Roche Diabetes Therapeutics and Diagnostics Introduction
11.22.4 Roche Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.22.5 Roche Recent Development
11.23 Sanofi
11.23.1 Sanofi Company Details
11.23.2 Sanofi Business Overview
11.23.3 Sanofi Diabetes Therapeutics and Diagnostics Introduction
11.23.4 Sanofi Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.23.5 Sanofi Recent Development
11.24 Takeda Pharmaceutical Co. Ltd.
11.24.1 Takeda Pharmaceutical Co. Ltd. Company Details
11.24.2 Takeda Pharmaceutical Co. Ltd. Business Overview
11.24.3 Takeda Pharmaceutical Co. Ltd. Diabetes Therapeutics and Diagnostics Introduction
11.24.4 Takeda Pharmaceutical Co. Ltd. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.24.5 Takeda Pharmaceutical Co. Ltd. Recent Development
11.25 Terumo Corp.
11.25.1 Terumo Corp. Company Details
11.25.2 Terumo Corp. Business Overview
11.25.3 Terumo Corp. Diabetes Therapeutics and Diagnostics Introduction
11.25.4 Terumo Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021)
11.25.5 Terumo Corp. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Diabetes Therapeutics and Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Insulin
Table 3. Key Players of Insulin Delivery
Table 4. Key Players of Oral Hypoglycemic Drugs
Table 5. Key Players of Diagnosis And Monitoring
Table 6. Key Players of Others
Table 7. Global Diabetes Therapeutics and Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Diabetes Therapeutics and Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Diabetes Therapeutics and Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Diabetes Therapeutics and Diagnostics Market Share by Regions (2016-2021)
Table 11. Global Diabetes Therapeutics and Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Diabetes Therapeutics and Diagnostics Market Share by Regions (2022-2027)
Table 13. Diabetes Therapeutics and Diagnostics Market Trends
Table 14. Diabetes Therapeutics and Diagnostics Market Drivers
Table 15. Diabetes Therapeutics and Diagnostics Market Challenges
Table 16. Diabetes Therapeutics and Diagnostics Market Restraints
Table 17. Global Diabetes Therapeutics and Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Diabetes Therapeutics and Diagnostics Market Share by Players (2016-2021)
Table 19. Global Top Diabetes Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Therapeutics and Diagnostics as of 2020)
Table 20. Ranking of Global Top Diabetes Therapeutics and Diagnostics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Diabetes Therapeutics and Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Diabetes Therapeutics and Diagnostics Product Solution and Service
Table 24. Date of Enter into Diabetes Therapeutics and Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Diabetes Therapeutics and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Type (2016-2021)
Table 28. Global Diabetes Therapeutics and Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Diabetes Therapeutics and Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Application (2016-2021)
Table 32. Global Diabetes Therapeutics and Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Diabetes Therapeutics and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Diabetes Therapeutics and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Diabetes Therapeutics and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Diabetes Therapeutics and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Diabetes Therapeutics and Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Diabetes Therapeutics and Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Diabetes Therapeutics and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Diabetes Therapeutics and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Diabetes Therapeutics and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Diabetes Therapeutics and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Diabetes Therapeutics and Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Diabetes Therapeutics and Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Diabetes Therapeutics and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Diabetes Therapeutics and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Diabetes Therapeutics and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Diabetes Therapeutics and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Diabetes Therapeutics and Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Diabetes Therapeutics and Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 64. 77 Elektronika Kft. Company Details
Table 65. 77 Elektronika Kft. Business Overview
Table 66. 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Product
Table 67. 77 Elektronika Kft. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 68. 77 Elektronika Kft. Recent Development
Table 69. A. Menarini Diagnostics S.R.L Company Details
Table 70. A. Menarini Diagnostics S.R.L Business Overview
Table 71. A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Product
Table 72. A. Menarini Diagnostics S.R.L Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 73. A. Menarini Diagnostics S.R.L Recent Development
Table 74. Abbott Laboratories Company Details
Table 75. Abbott Laboratories Business Overview
Table 76. Abbott Laboratories Diabetes Therapeutics and Diagnostics Product
Table 77. Abbott Laboratories Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 78. Abbott Laboratories Recent Development
Table 79. Agamatrix Inc. Company Details
Table 80. Agamatrix Inc. Business Overview
Table 81. Agamatrix Inc. Diabetes Therapeutics and Diagnostics Product
Table 82. Agamatrix Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 83. Agamatrix Inc. Recent Development
Table 84. Animas Corp. Company Details
Table 85. Animas Corp. Business Overview
Table 86. Animas Corp. Diabetes Therapeutics and Diagnostics Product
Table 87. Animas Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 88. Animas Corp. Recent Development
Table 89. Ascensia Company Details
Table 90. Ascensia Business Overview
Table 91. Ascensia Diabetes Therapeutics and Diagnostics Product
Table 92. Ascensia Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 93. Ascensia Recent Development
Table 94. Becton Dickinson Company Details
Table 95. Becton Dickinson Business Overview
Table 96. Becton Dickinson Diabetes Therapeutics and Diagnostics Product
Table 97. Becton Dickinson Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 98. Becton Dickinson Recent Development
Table 99. Debiotech S.A. Company Details
Table 100. Debiotech S.A. Business Overview
Table 101. Debiotech S.A. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 102. Debiotech S.A. Recent Development
Table 103. Eli Lilly And Co. Company Details
Table 104. Eli Lilly And Co. Business Overview
Table 105. Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Product
Table 106. Eli Lilly And Co. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 107. Eli Lilly And Co. Recent Development
Table 108. Glaxo Smithkline Company Details
Table 109. Glaxo Smithkline Business Overview
Table 110. Glaxo Smithkline Diabetes Therapeutics and Diagnostics Product
Table 111. Glaxo Smithkline Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 112. Glaxo Smithkline Recent Development
Table 113. Inlight Solutions Inc. Company Details
Table 114. Inlight Solutions Inc. Business Overview
Table 115. Inlight Solutions Inc. Diabetes Therapeutics and Diagnostics Product
Table 116. Inlight Solutions Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 117. Inlight Solutions Inc. Recent Development
Table 118. Johnson & Johnson Company Details
Table 119. Johnson & Johnson Business Overview
Table 120. Johnson & Johnson Diabetes Therapeutics and Diagnostics Product
Table 121. Johnson & Johnson Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 122. Johnson & Johnson Recent Development
Table 123. Lifescan Inc. Company Details
Table 124. Lifescan Inc. Business Overview
Table 125. Lifescan Inc. Diabetes Therapeutics and Diagnostics Product
Table 126. Lifescan Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 127. Lifescan Inc. Recent Development
Table 128. Medtronic Company Details
Table 129. Medtronic Business Overview
Table 130. Medtronic Diabetes Therapeutics and Diagnostics Product
Table 131. Medtronic Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 132. Medtronic Recent Development
Table 133. Merck & Co. Company Details
Table 134. Merck & Co. Business Overview
Table 135. Merck & Co. Diabetes Therapeutics and Diagnostics Product
Table 136. Merck & Co. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 137. Merck & Co. Recent Development
Table 138. Merck KGAA Company Details
Table 139. Merck KGAA Business Overview
Table 140. Merck KGAA Diabetes Therapeutics and Diagnostics Product
Table 141. Merck KGAA Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 142. Merck KGAA Recent Development
Table 143. Nipro Corp. Company Details
Table 144. Nipro Corp. Business Overview
Table 145. Nipro Corp. Diabetes Therapeutics and Diagnostics Product
Table 146. Nipro Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 147. Nipro Corp. Recent Development
Table 148. Novartis Pharma Ag Company Details
Table 149. Novartis Pharma Ag Business Overview
Table 150. Novartis Pharma Ag Diabetes Therapeutics and Diagnostics Product
Table 151. Novartis Pharma Ag Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 152. Novartis Pharma Ag Recent Development
Table 153. Novo Nordisk A/S Company Details
Table 154. Novo Nordisk A/S Business Overview
Table 155. Novo Nordisk A/S Diabetes Therapeutics and Diagnostics Product
Table 156. Novo Nordisk A/S Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 157. Novo Nordisk A/S Recent Development
Table 158. Owen Mumford Ltd. Company Details
Table 159. Owen Mumford Ltd. Business Overview
Table 160. Owen Mumford Ltd. Diabetes Therapeutics and Diagnostics Product
Table 161. Owen Mumford Ltd. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 162. Owen Mumford Ltd. Recent Development
Table 163. Palco Labs Inc. Company Details
Table 164. Palco Labs Inc. Business Overview
Table 165. Palco Labs Inc. Diabetes Therapeutics and Diagnostics Product
Table 166. Palco Labs Inc. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 167. Palco Labs Inc. Recent Development
Table 168. Roche Company Details
Table 169. Roche Business Overview
Table 170. Roche Diabetes Therapeutics and Diagnostics Product
Table 171. Roche Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 172. Roche Recent Development
Table 173. Sanofi Company Details
Table 174. Sanofi Business Overview
Table 175. Sanofi Diabetes Therapeutics and Diagnostics Product
Table 176. Sanofi Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 177. Sanofi Recent Development
Table 178. Takeda Pharmaceutical Co. Ltd. Company Details
Table 179. Takeda Pharmaceutical Co. Ltd. Business Overview
Table 180. Takeda Pharmaceutical Co. Ltd. Diabetes Therapeutics and DiagnosticsProduct
Table 181. Takeda Pharmaceutical Co. Ltd. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 182. Takeda Pharmaceutical Co. Ltd. Recent Development
Table 183. Terumo Corp. Company Details
Table 184. Terumo Corp. Business Overview
Table 185. Terumo Corp. Diabetes Therapeutics and Diagnostics Product
Table 186. Terumo Corp. Revenue in Diabetes Therapeutics and Diagnostics Business (2016-2021) & (US$ Million)
Table 187. Terumo Corp. Recent Development
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetes Therapeutics and Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Insulin Features
Figure 3. Insulin Delivery Features
Figure 4. Oral Hypoglycemic Drugs Features
Figure 5. Diagnosis And Monitoring Features
Figure 6. Others Features
Figure 7. Global Diabetes Therapeutics and Diagnostics Market Share by Application: 2020 VS 2027
Figure 8. Type 1 Diabetes Case Studies
Figure 9. Type 2 Diabetes Case Studies
Figure 10. Gestational Diabetes Case Studies
Figure 11. Others Case Studies
Figure 12. Diabetes Therapeutics and Diagnostics Report Years Considered
Figure 13. Global Diabetes Therapeutics and Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Diabetes Therapeutics and Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Diabetes Therapeutics and Diagnostics Market Share by Regions: 2020 VS 2027
Figure 16. Global Diabetes Therapeutics and Diagnostics Market Share by Regions (2022-2027)
Figure 17. Global Diabetes Therapeutics and Diagnostics Market Share by Players in 2020
Figure 18. Global Top Diabetes Therapeutics and Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetes Therapeutics and Diagnostics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Diabetes Therapeutics and Diagnostics Revenue in 2020
Figure 20. Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Type (2016-2021)
Figure 21. Global Diabetes Therapeutics and Diagnostics Revenue Market Share by Type (2022-2027)
Figure 22. North America Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Diabetes Therapeutics and Diagnostics Market Share by Type (2016-2027)
Figure 24. North America Diabetes Therapeutics and Diagnostics Market Share by Application (2016-2027)
Figure 25. North America Diabetes Therapeutics and Diagnostics Market Share by Country (2016-2027)
Figure 26. United States Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Diabetes Therapeutics and Diagnostics Market Share by Type (2016-2027)
Figure 30. Europe Diabetes Therapeutics and Diagnostics Market Share by Application (2016-2027)
Figure 31. Europe Diabetes Therapeutics and Diagnostics Market Share by Country (2016-2027)
Figure 32. Germany Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Diabetes Therapeutics and Diagnostics Market Share by Region (2016-2027)
Figure 42. China Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Diabetes Therapeutics and Diagnostics Market Share by Type (2016-2027)
Figure 50. Latin America Diabetes Therapeutics and Diagnostics Market Share by Application (2016-2027)
Figure 51. Latin America Diabetes Therapeutics and Diagnostics Market Share by Country (2016-2027)
Figure 52. Mexico Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Diabetes Therapeutics and Diagnostics Market Share by Country (2016-2027)
Figure 58. Turkey Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Diabetes Therapeutics and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. 77 Elektronika Kft. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 62. A. Menarini Diagnostics S.R.L Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 63. Abbott Laboratories Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 64. Agamatrix Inc. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 65. Animas Corp. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 66. Ascensia Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 67. Becton Dickinson Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 68. Debiotech S.A. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 69. Eli Lilly And Co. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 70. Glaxo Smithkline Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 71. Inlight Solutions Inc. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 72. Johnson & Johnson Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 73. Lifescan Inc. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 74. Medtronic Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 75. Merck & Co. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 76. Merck KGAA Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 77. Nipro Corp. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 78. Novartis Pharma Ag Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 79. Novo Nordisk A/S Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 80. Owen Mumford Ltd. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 81. Palco Labs Inc. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 82. Roche Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 83. Sanofi Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 84. Takeda Pharmaceutical Co. Ltd. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 85. Terumo Corp. Revenue Growth Rate in Diabetes Therapeutics and Diagnostics Business (2016-2021)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
世界の糖尿病用非インスリン療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Non-Insulin Therapies for Diabetes Market The global Non-Insulin Therapies for Diabetes market size is projected to reach US$ 54930 million by 2026, from US$ 30040 million in 2019, at a CAGR of 8.9% during 2021-2026. With industry-standard accuracy in analysis an…- 世界の糖尿病治療・ドラッグデリバリー市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Diabetes Therapy and Drug Delivery Market The global Diabetes Therapy and Drug Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high …
- 世界の次世代糖尿病治療＆ドラッグデリバリー市場規模・現状・予測（2021年-2027年） Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level. The market growth is attributed to the rise in the number of diabetic patients globally …
- 世界の針なし糖尿病治療市場規模・現状・予測（2021年-2027年） Diabetes is a metabolic disorder in this condition person will have high blood glucose levels than the normal blood glucose. This is mainly due to inadequate insulin production or body cells are unable to respond to the produced insulin in the body or both. Symptoms of Diabetes are hyperglycemic con…
- 世界の針なし糖尿病治療市場規模・現状・予測（2021年-2027年） Diabetes is a metabolic disorder in this condition person will have high blood glucose levels than the normal blood glucose. This is mainly due to inadequate insulin production or body cells are unable to respond to the produced insulin in the body or both. Symptoms of Diabetes are hyperglycemic con…